glp 1 and female hormones Sex Differences in Response to Treatment with Glucagon-like Peptide Receptor Agonists: Opportunities for a Tailored Approach to Diabetes Obesity Care GLP-1 in Endometriosis: What We

Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases

rates: 3.71 versus 3.56

NO RISK

Strawberry Acai Flavor Enjoy A Naturally Inspired Fruity Taste That Simply Blend With Water Or Your Favorite Beverage For A Smooth, Refreshing Drink At Home, Work, Or On The Go

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass